Firebrick Pharma Limited (AU:FRE) has released an update.
Firebrick Pharma Limited has announced the issue of 1.5 million new unquoted options expiring in September 2027, priced at $0.09, as detailed in their latest Appendix 3G filing on September 10, 2024. These options form part of a series of transactions previously disclosed and will not be quoted on the ASX.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.
